Pyrido[2,3-d]pyrimidin-5-ones: a novel class of antiinflammatory macrophage colony-stimulating factor-1 receptor inhibitors.
暂无分享,去创建一个
R. DesJarlais | Hui-Sheng Huang | M. Player | C. Schubert | C. Manthey | W. Parsons | E. Yurkow | C. Crysler | Yanmin Chen | M. Chaikin | Robert R Donatelli | Zhao Zhou | Huaping Hu | Deping Cheng | J. M. Rinker | D. A. Hutta | J. Rinker
[1] Issa J Dahabreh,et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis: a systematic review and meta-analysis of dosage regimens. , 2008, Clinical therapeutics.
[2] T. Brodie,et al. Effects of the cFMS Kinase Inhibitor 5-(3-Methoxy-4-((4-methoxybenzyl)oxy)benzyl)pyrimidine-2,4-diamine (GW2580) in Normal and Arthritic Rats , 2008, Journal of Pharmacology and Experimental Therapeutics.
[3] Jinsheng Chen,et al. Structure-based optimization of a potent class of arylamide FMS inhibitors. , 2008, Bioorganic & medicinal chemistry letters.
[4] A. Kavanaugh,et al. Biologic therapy for early rheumatoid arthritis: the latest evidence , 2008, Current opinion in rheumatology.
[5] R. DesJarlais,et al. Design and synthesis of a pyrido[2,3-d]pyrimidin-5-one class of anti-inflammatory FMS inhibitors. , 2008, Bioorganic & medicinal chemistry letters.
[6] B. Tomczuk,et al. Synthesis and evaluation of novel 3,4,6-substituted 2-quinolones as FMS kinase inhibitors. , 2008, Bioorganic & medicinal chemistry letters.
[7] B. Tomczuk,et al. Discovery of novel FMS kinase inhibitors as anti-inflammatory agents. , 2008, Bioorganic & medicinal chemistry letters.
[8] Isao Serizawa,et al. The selective M-CSF receptor tyrosine kinase inhibitor Ki20227 suppresses experimental autoimmune encephalomyelitis , 2008, Journal of Neuroimmunology.
[9] I. Serizawa,et al. The orally‐active and selective c‐Fms tyrosine kinase inhibitor Ki20227 inhibits disease progression in a collagen‐induced arthritis mouse model , 2008, European journal of immunology.
[10] W. Cheung,et al. Potent 2'-aminoanilide inhibitors of cFMS as potential anti-inflammatory agents. , 2007, Bioorganic & medicinal chemistry letters.
[11] B. Grasberger,et al. Protein Engineering of the Colony-stimulating Factor-1 Receptor Kinase Domain for Structural Studies* , 2006, Journal of Biological Chemistry.
[12] Mark R Player,et al. Crystal Structure of the Tyrosine Kinase Domain of Colony-stimulating Factor-1 Receptor (cFMS) in Complex with Two Inhibitors* , 2006, Journal of Biological Chemistry.
[13] Yujia Dai,et al. Inhibition of phosphorylation of the colony-stimulating factor-1 receptor (c-Fms) tyrosine kinase in transfected cells by ABT-869 and other tyrosine kinase inhibitors , 2006, Molecular Cancer Therapeutics.
[14] H. Ichijo,et al. Enhanced TNF-alpha-induced apoptosis in Fanconi anemia type C-deficient cells is dependent on apoptosis signal-regulating kinase 1. , 2005, Blood.
[15] S. Teitelbaum,et al. M-CSF mediates TNF-induced inflammatory osteolysis. , 2005, The Journal of clinical investigation.
[16] J. Parham,et al. Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[17] D. Hume,et al. The Colony-Stimulating Factor 1 Receptor Is Expressed on Dendritic Cells during Differentiation and Regulates Their Expansion1 , 2005, The Journal of Immunology.
[18] A. Zwinderman,et al. Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis , 2004, Annals of the rheumatic diseases.
[19] F. Pixley,et al. CSF-1 regulation of the wandering macrophage: complexity in action. , 2004, Trends in cell biology.
[20] M. Gershwin,et al. The use of methotrexate in rheumatoid arthritis. , 2004, Seminars in arthritis and rheumatism.
[21] S. Wahl,et al. Intraarticular gene transfer of TNFR:Fc suppresses experimental arthritis with reduced systemic distribution of the gene product. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.
[22] K. Hino,et al. Synthesis and structure-activity relationships of novel 7-substituted 1,4-dihydro-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acids as antitumor agents. Part 1. , 2002, Journal of medicinal chemistry.
[23] Yong-Beom Park,et al. Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound. , 2002, Arthritis and rheumatism.
[24] P. Richards,et al. Suppression of chronic streptococcal cell wall-induced arthritis in Lewis rats by liposomal clodronate. , 2001, Rheumatology.
[25] J. Cherrington,et al. The antiangiogenic protein kinase inhibitors SU5416 and SU6668 inhibit the SCF receptor (c-kit) in a human myeloid leukemia cell line and in acute myeloid leukemia blasts. , 2001, Blood.
[26] J. Hamilton,et al. The colony‐stimulating factors and collagen‐induced arthritis: exacerbation of disease by M‐CSF and G‐CSF and requirement for endogenous M‐CSF , 2000, Journal of leukocyte biology.
[27] S. Santavirta,et al. High macrophage-colony stimulating factor levels in synovial fluid of loose artificial hip joints. , 2000, The Journal of rheumatology.
[28] 手塚 建一,et al. 骨芽細胞様細胞が産生する Macrophage colony-stimulating factor は後期分化にある破骨細胞のサバイバルファクターである , 1997 .
[29] F. Breedveld,et al. Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity. , 1997, Arthritis and rheumatism.
[30] Hidemi,et al. [Macrophage colony-stimulating factor in patients with rheumatoid arthritis]. , 1995, Nihon Ika Daigaku zasshi.
[31] R. Bucala,et al. Sustained and Distinctive Patterns of Gene Activation in Synovial Fibroblasts and Whole Synovial Tissue Obtained from Inflammatory Synovitis , 1994, Scandinavian journal of immunology.
[32] Wei Li,et al. Phase I trial of recombinant macrophage colony-stimulating factor and recombinant gamma-interferon: toxicity, monocytosis, and clinical effects. , 1994, Cancer research.
[33] J. Hamilton,et al. Rheumatoid arthritis: opposing actions of haemopoietic growth factors and slow-acting anti-rheumatic drugs , 1993, The Lancet.
[34] S. Hirohata,et al. Phenotypic analysis of peripheral blood monocytes isolated from patients with rheumatoid arthritis. , 1992, The Journal of rheumatology.
[35] S. Epstein,et al. Osteoporosis associated with rheumatoid arthritis: pathogenesis and management. , 1991, Seminars in arthritis and rheumatism.
[36] Y. Tohda,et al. Nucleophilic Reaction upon Electron-Deficient Pyridone Derivatives. X.One-Pot Synthesis of 3-Nitropyridines by Ring Transformation of 1-Methyl-3,5-dinitro-2-pyridone with Ketones or Aldehydes in the Presence of Ammonia , 1990 .
[37] D. Housman,et al. The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene , 1988, Cell.
[38] A. Orlofsky,et al. CSF‐1‐induced gene expression in macrophages: dissociation from the mitogenic response. , 1987, The EMBO journal.
[39] C. Swindell,et al. A Useful Construction of 4‐Substituted 1‐Alkylpiperid‐3‐ones. , 1987 .
[40] C. Sherr,et al. Specific binding of the mononuclear phagocyte colony-stimulating factor CSF-1 to the product of the v-fms oncogene. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[41] W. Wiktor-Jedrzejczak,et al. Hematological characterization of congenital osteopetrosis in op/op mouse. Possible mechanism for abnormal macrophage differentiation , 1982, The Journal of experimental medicine.
[42] W. J. Cromartie,et al. Arthritis in rats after systemic injection of streptococcal cells or cell walls , 1977, The Journal of experimental medicine.
[43] B. Rini,et al. Antitumor effects of sunitinib or sorafenib in patients with metastatic renal cell carcinoma who received prior antiangiogenic therapy. , 2008, The Journal of urology.
[44] C. Liang,et al. SU 14813 : a novel multiple receptor tyrosine kinase inhibitor with potent antiangiogenic and antitumor activity , 2006 .
[45] R. Russell,et al. Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. , 2002, Blood.
[46] J. Pollard,et al. Pleiotropic Roles for CSF-1 in Development Defined by the Mouse Mutation Osteopetrotic , 1996 .
[47] M. Ratajczak,et al. The c-kit proto-oncogene in normal and malignant human hematopoiesis. , 1992, International journal of cell cloning.